Evidence-Based Medicine

Listeria Meningitis

Listeria Meningitis

Background

  • Listeria monocytogenes, primarily a foodborne pathogen, is among the leading causes of bacterial meningitis in the United States.
  • L. monocytogenes infection preferentially affects neonates, the elderly, pregnant women, and others with impaired cell-mediated immunity.
  • The organism has tropism for the central nervous system and in addition to meningitis, may also cause meningoencephalitis, rhombencephalitis (brainstem encephalitis), and brain abscesses.
  • Symptoms of listerial meningitis commonly include fever and headache; nuchal rigidity may be less common than with other common causes of community-acquired bacterial meningitis.
  • Rhombencephalitis due to Listeria is uncommon and typically presents with a prodrome of fever, headache, nausea, and vomiting followed by the onset of brainstem symptoms such as cranial nerve palsies, vertigo, and hemiataxia.
  • Cerebral abscesses due to Listeria are rare, and most commonly present with fever, headache, and focal neurologic deficits in immunocompromised patients.
  • Mortality associated with listerial central nervous system (CNS) infections ranges from about 17% to 51%, even with antibiotic therapy.

Evaluation

  • Cerebrospinal fluid (CSF) analysis is recommended for patients with suspected meningitis (Strong recommendation).
  • CSF profile in Listeria meningitis typically shows:
    • pleocytosis in about 75% of patients:
      • generally about 500-600 cells/mm3
      • typically neutrophil-predominant but may be mixed with monocytes or lymphocytes
    • elevated protein in about 50% of patients
    • low or normal glucose
    • Gram stain shows gram-positive or gram-variable rods in about 30%
  • Definitive diagnosis is made by
    • isolation of Listeria from blood or CSF
      • CSF cultures are positive in about 80% of cases.
      • Blood cultures are positive in about 75%, but ranges of 19%-88% reported in case series.
    • molecular identification of Listeria monocytogenes from CSF.
  • In rhombencephalitis, CSF pleocytosis is less common. CSF and blood cultures are positive in about 30%-50% of cases. Computed tomography (CT) scan or magnetic resonance imaging (MRI) of the brain may show small brainstem abscesses, widening of the brainstem, and hydrocephalus.
  • With cerebral abscesses, blood cultures are often positive while CSF cultures are positive in less than half of cases. A CT scan or MRI is needed to localize lesions.

Management

  • Ampicillin is the preferred treatment for listerial central nervous system (CNS) infections.
  • Add ampicillin, 2 g IV every 4 hours, to empiric vancomycin and ceftriaxone for adults at high risk for listerial infection (Strong recommendation) including:
    • patients < 1 month old or > 50 years old
    • immunocompromised patients
    • patients with signs of rhombencephalitis
  • For confirmed listerial meningitis (Strong recommendation):
    • Consider addition of gentamicin to ampicillin.
    • Gentamicin has demonstrated in vitro synergy but the clinical benefit is unclear.
  • Treatment for listerial meningitis should be given for ≥ 21 days (Strong recommendation).
  • Co-trimoxazole (trimethoprim-sulfamethoxazole) and meropenem are alternatives for penicillin-allergic patients with reported efficacy in case series and reports.
  • For other listerial CNS infections, ampicillin is most commonly used but experience managing such infections is limited.

Published: 13-07-2023 Updeted: 13-07-2023

References

  1. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004 Nov 1;39(9):1267-84, summary can be found in Am Fam Physician 2005 May 15;71(10):2003 full-text, commentary can be found in Clin Infect Dis 2005 Apr 1;40(7):1061
  2. Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008 Jul;15(7):649-59
  3. Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2010 Jul;23(3):467-92
  4. Drevets DA, Bronze MS. Listeria monocytogenes: epidemiology, human disease, and mechanisms of brain invasion. FEMS Immunol Med Microbiol. 2008 Jul;53(2):151-65
  5. Disson O, Lecuit M. In vitro and in vivo models to study human listeriosis: mind the gap. Microbes Infect. 2013 Dec;15(14-15):971-80
  6. Bartt R. Listeria and atypical presentations of Listeria in the central nervous system. Semin Neurol. 2000;20(3):361-73
  7. Posfay-Barbe KM, Wald ER. Listeriosis. Semin Fetal Neonatal Med. 2009 Aug;14(4):228-33

Related Topics